The results of a new study to detect lung cancer, that a new way to diagnose a substitute for the work of a surgical procedure is expensive and carries risks that might threaten the patient's life. The accuracy as a result of new diagnosis method in excess of 90 percent.
New studies data showed that the new diagnostic test for the company "Verasaat" may avoid many serious surgical procedure and expensive to take a sample of cells or analysis or examination in the laboratory tissue (Baaobsi) at a time when millions of Americans are smokers undergoing tests especially lung cancer.
The test is named (Persebta Pronkaal Jinomak Clasavair) to take samples of the cell from the trachea to the smoker through a medical procedure known as a bronchoscopy in which the endoscope is used to seeing respiratory tracks and analyze genes to learn how to be affected by exposure to toxins cigarettes.
Said Dr. Avromm Spiro of Boston University School of Medicine in co-innovation test and who oversaw the investigative studies "of these cells such as Detective ... It tells us whether this node in the depth of lung cancer are likely."
When CT scans indicate that there is something abnormal in the lung patient undergoes a colonoscopy who enters a small camera into the trachea in an attempt to see the area concerned. And fails 40 percent of the attempts to reach a definitive diagnosis and often it is because the camera was not able to access the site of the suspect.
And explains Spiro, saying "the only way that we become unsure of which, is planting a needle in the chest or chest wall surgery is open. We do not want to lose sight of the cancerous tumor and end up surgery or Baobab for many cancer patients are not. "
After the CT scan and colonoscopy test evaluates patients at risk of cancer by high, medium or low. Spiro says that the test provided Asseverate company is particularly well suited to the group that has a medium risk and he was able to re-diagnosed as at risk of low-grade cancer diagnosis and amounted to 91 percent accuracy. This means that this group can be pursued through a CT scan without having to Albatross.
Said Spiro, who studies presented at a meeting of the American Society of Chest Physicians in Denver "We now have a new tool to help us assess the smokers at risk for lung cancer and to identify those who do not need to conduct a surgical Toga."
And the use of a needle Albatross involve risk of between 15 and 25 percent in the pathogens of pulmonary collapse, while Albatross surgical procedure costing between 3,000 and 4,000 dollars.
This means that this group can be pursued through a CT scan without having to Albatross.
Said Spiro, who studies presented at a meeting of the American Society of Chest Physicians in Denver "We now have a new tool to help us assess the smokers at risk for lung cancer and to identify those who do not need to conduct a surgical Toga."
And the use of a needle Albatross involve risk of between 15 and 25 percent in the parthenogenesis of pulmonary collapse, while Albatross surgical procedure costing between 3,000 and 4,000 dollars.